READ MORE...Reuters.co.uk: "GlaxoSmithKline has restarted talks to buy Europe's biggest biotech company Serono for a lower price, after an auction for up to $15 billion (8.5 billion pounds) failed to find buyers, people familiar with the situation said on Sunday.Serono of Switzerland, which specialises in multiple sclerosis and infertility treatments, said in November it had received a number of bid approaches and had hired U.S. investment bank Goldman Sachs to run a sale.But no bids were received by an auction deadline of January 20, as potential buyers balked at the high cash price being demanded by Ernesto Bertarelli, the chief executive of Serono, whose family holds 62 percent of the capital."